About PsychoGenics
With comprehensive translational services that deliver on your needs, we’re dedicated to driving your progress so you can discover the next generation of breakthrough CNS therapies.
Where Passion Powers CNS Drug Discovery
Teamwork. Excellence. Creativity. Entrepreneurial spirit.
The Proven Power of Experience
years of experience
client relationships with more than 70% of clients returning
%
team members with a Ph.D
disease models
behavioral assays
Our Latest Updates
-
View By:
- News
- Resources
- Events
PsychoGenics Awarded an NIH Contract to Test and Identify Novel Therapeutics for Pain
PARAMUS, N.J., October 8, 2024 –– PsychoGenics Inc. (PsychoGenics) today announced it has been awarded a contract by the National Institutes of Health (NIH) to test and identify novel investigational therapeutics for the treatment of pain. The lack of safe and...
PsychoGenics Inc. Awarded $3 million SBIR Grant to Employ its AI-enabled Platforms to Find Treatments for Rare Disorders
PARAMUS, NEW JERSEY, August 28, 2024 - PsychoGenics, a leader in AI-enabled phenotypic drug discovery, has been awarded a Fast Track Small Business Innovation Research (SBIR) grant by NIMH, worth up to $3 million over four years. This grant will support PsychoGenics...
Back to the future: From target-selective drug design to AI-enabled polypharmacology
Sleep/Wake and Pharmaco-EEG Capabilities
Thorough analyses of Electroencephalography (EEG) following pharmacological or genetic manipulations requires careful determination of sleep/wake profiles. EEG power is significantly different during normal waking compared to normal non-rapid eye movement (NREM) and...
Standardized Spinal Cord Injury Platform for Preclinical Research
Johana Bastidas1, Megan R. Detloff2, Linda Jones3, Marco Baptista3, Karim Fouad4, Wolfram Tetzlaff 5, Taleen Hanania11PsychoGenics, Paramus, New Jersey, US, 2Department of Neurobiology & Anatomy, Marion Murray Spinal Cord Research Center, Drexel University College...
Autism Spectrum Disorder (ASD) is a multifaceted neurodevelopmental condition characterized by challenges in social interaction, communication, and behavior.
Approximately 2% of individuals with ASD carry mutations in the Shank3 gene, which plays a crucial role in organizing neuronal connections. Shank3B-KO mice, developed by Professor Guoping Feng at MIT, harbor a deletion of exons 13-16 of the PDZ domains...
Explore PsychoGenics
About Us
Leadership Team
About Us
Culture
About Us